ColoPlus, A New Product Based On Bovine Colostrum, Alleviates HIV-associated Diarrhoea
| Effect | Increase |
| Trial Design | Cohort |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 30 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64 |
In HIV-infected persons with associated diarrhea, a colostrum containing porridge known as ColoPlus (32% colostrum, where each 50g pack contained 2-4g immunoglobulins and is taken twice daily) for four weeks was able to greatly reduce daily bowel movements from 7 down to 1.6, the benefit lasting for an additional two weeks after supplement cessation.
It was noted that CD4+ lymphocytes increased in all persons, to a larger degree in those with less than 200 cells per microliter (experiencing a 94-110% increase) and that fatigue associated with HIV was reduced 81%.
